Use of luteinizing hormone releasing hormone agonists in polycystic ovary syndrome

Bailliere's Clinical Obstetrics and Gynaecology

Volumn 12, Issue 4, 1998, Pages 593-606

  Buckett, W M ^a   Tan, S L ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Gonadotrophin releasing hormone agonists; In vitro fertilization; Luteinizing hormone releasing hormone agonists; Ovarian hyperstimulation syndrome; Ovulation induction; Polycystic ovary syndrome; Protocols

Indexed keywords

CLOMIFENE CITRATE; FERTILITY PROMOTING AGENT; GONADORELIN AGONIST;

FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; GAMETE INTRAFALLOPIAN TRANSFER; HUMAN; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; SUPEROVULATION;

EID: 0031782601     PISSN: 09503552     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3552(98)80054-0     Document Type: Article

References (77)

1. Amso NN Ahuja KK Morris N Shaw RW The management of predicted ovarian hyperstimulation involving gonadotrophin-releasing hormone analog with elective cryopreservation of all pre-embryos Fertility and Sterility 53 1990 1087 1090
2. Andreyko JL Marshall LA Dumesic DA Jaffe AB Therapeutic uses of gonadotrophin-releasing hormone analogs Obstetrical and Gynecological Survey 42 1987 1 21
3. Asch RH Ivery G Goldsman M The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome Human Reproduction 8 1993 1015 1020
4. Ashkenazi J Goldman JA Dicker D Adverse neurological symptoms after gonadotrophin-releasing hormone analog therapy for in vitro fertilization cycles Fertility and Sterility 53 1990 738 740
5. Awonuga AO Dean N Zaidi J Outcome of frozen embryo replacement cycles following elective cryopreservation of all embryos in women at risk of ovarian hyperstimulation syndrome Journal of Assisted Reproduction and Genetics 13 1996 293 297
6. Awonuga AO Pittrof RU Zaidi J Elective cryopreservation of all embryos in women at risk of developing ovarian hyperstimulation syndrome may not prevent the condition but reduces the live birth rate Journal of Assisted Reproduction and Genetics 13 1996 401 406
7. Balen AH Tan SL MacDougall J Jacobs HS Miscarriage rates following in vitro fertilization are increased in women with polycystic ovaries and reduced by desensitization with buserelin Human Reproduction 8 1993 959 964
8. Barriere P Lopes P Boiffard JP Use of GnRH analogues in ovulation induction for in vitro fertilization: benefit of a short administration regimen Journal of In Vitro Fertilization and Embryo Transfer 4 1987 64 65
9. Battaglia C Artini PG Ganazzi AD Color doppler analysis in oligo- and amenorrheic women with polycystic ovary syndrome Gynecologic Endocrinology 11 1997 105 110
10. Belchetz PE Plant TM Nakai Y Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotrophin-releasing hormone Science 202 1978 631 633
11. abstract A108 Biljan MM Dean N Hemmings R The effect of administration of the oral contraceptive pill on the incidence of ovarian cyst formation during pituitary suppression 7th World Congress on Ultrasound in Obstetrics and Gynecology Washington, DC 1997
12. Bramley TA Menzies GS Baird DT Specific binding of gonadotrophin-releasing hormone and an agonist to human corpus luteum homogenates: characterization, properties, and luteal phase levels Journal of Clinical Endocrinology and Metabolism 61 1985 834 841
13. Buckett WM Bentick B Shaw RW Induction of the endogenous gonadotrophin surge for oocyte maturation with intra-nasal gonadotrophin-releasing hormone analogue (buserelin): effective minimal dose Human Reproduction 13 1998 811 814
14. Cahill DJ The risks of GnRH agonist administration in early pregnancy Filicori M Flamigni C Ovulation Induction Update '98 1998 Parthenon London 97 106
15. Chang SY Soong YK Unexpected pregnancies exposed to leuprolide acetate administered after the mid-luteal phase for ovarian stimulation Human Reproduction 10 1995 204 206
16. Clifford K Rai R Watson H Regan L An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases Human Reproduction 9 1994 1328 1332
17. Clifford K Rai R Watson H Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial British Medical Journal 312 1996 1508 1511
18. Daya S Optimal protocol for gonadotrophin releasing hormone agonist use in ovarian stimulation Gomel V Leung PCK In Vitro Fertilization and Assisted Reproduction 1997 Monduzzi Bologna 405 410
19. chap. 8 Derman SG McCormack HD Adashi EY Regulation of pituitary response to gonadotrophin releasing hormone Sciarra JJ Gynecology and Obstetrics vol 5 1987 Harper & Row New York 1 16
20. Dirnfield M Gonen Y Lissak A Randomized prospective study on the effect of short and long buserelin treatment in women with repeated unsuccessful in vitro fertilization (IVF) cycles due to inadequate ovarian response Journal of In Vitro Fertilization and Embryo Transfer 8 1991 339 343
21. Dodson WC Hughes CL Whitesides DB Haney AF The effect of leuprolide acetate on ovulation induction with HMG in PCOS Journal of Clinical Endocrinology and Metabolism 65 1987 95 100
22. Engmann L, Maconochie N, Bekir JS et al (submitted) Multiple cycle package improves the ultimate prospects of success in an in vitro fertilization programme. British Journal of Obstetrics and Gynaecology .
23. Farhi J Homburg R Lerner A Ben-Rafael Z The choice of treatment for anovulation associated with polycystic ovary syndrome following failure to conceive with clomiphene Human Reproduction 8 1993 1367 1371
24. Filicori M Flamigni C Dellai P Treatment of anovulation with pulsatile gonadotrophin-releasing hormone: prognostic factors and clinical results in 600 cycles Journal of Clinical Endocrinology and Metabolism 79 1994 1215 1220
25. Filicori M Pocognoli P Cognigni GE Use of pulsatile gonadotrophin-releasing hormone to induce monofolliculogenesis in polycystic ovary syndrome Filicori M Flamigni C Ovulation Induction Update '98 1998 Parthenon London 55 60
26. Forman RG Frydman R Egan D Severe ovarian hyperstimulation syndrome using agonists of gonadotrophin-releasing hormone for in-vitro fertilization: a European series and a proposal for prevention Fertility and Sterility 53 1990 502 509
27. Frydman R Belaisch-Allart J Parneix I Comparison between flare up and down regulation effects of luteinizing hormone releasing hormone agonists in an in vitro fertilization program Fertility and Sterility 50 1988 471 475
28. Furr BJA Pharmacological studies with Zoladex, a novel LHRH analogue Chishol GD Zoladex—a New Treatment for Prostatic Cancer 1987 RSM Services London 1 15
29. Gerhard I Matthes J Runnebaum B The induction of ovulation with pulsatile gonadotrophin releasing hormone (GnRH) administration in hyperandrogenic women after down-regulation with buserelin or suppression with an oral contraceptive Human Reproduction 8 1993 2033 2038
30. Gerris J De Vits A Joostens M Van Royen E Triggering of ovulation in human menopausal gonadotrophin stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 μg), GnRH agonist (buserelin, 500μg) and human chorionic gonadotrophin (10000 IU) Human Reproduction 10 1995 56 62
31. Gonen Y Dirnfield M Abramovici H Outcome of pregnancies inadvertently exposed to gonadotrophin-releasing hormone analogues (GnRH-a) in early gestation Journal of Assisted Reproduction and Genetics 10 1993 437 439
32. Hodgen GD Uses of GnRH analogues in IVF/GIFT Contemporary Obstetrics and Gynecology 35 1990 10 24
33. Hull MG Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies Gynecologic Endocrinology 1 1987 235 245
34. Insler V Lunenfeld E Potashnik G Levy J The combined pituitary suppression/ovarian stimulation therapy: myths and realities Mashiach S Ben-Rafael Z Laufer N Svhenker JG Advances in Assisted Reproductive Technologies 1990 Plenum New York 31 35
35. Jeffcoate SL Greenwood RH Holland DT Blood and urine clearance of luteinizing hormone releasing hormone in man measured by radioimmunoassay Journal of Endocrinology 60 1974 305 314
36. Kang IS Keuhl TJ Siler-Khodr TM Effect of treatment with gonadotrophin-releasing hormone analogues on pregnancy outcome in the baboon Fertility and Sterility 52 1989 846 853
37. Knobil E The neuroendocrine control of the menstrual cycle Recent Progress in Hormone Research 36 1980 53 88
38. Lanzone A Fulghesu AM Apa R LH surge induction by GnRH agonist at the time of ovulation Gynecologic Endocrinology 3 1989 213 220
39. MacDougall MJ Tan SL Jacobs HS In vitro fertilisation and the ovarian hyperstimulation syndrome Human Reproduction 7 1993 597 600
40. MacDougall MJ Tan SL Balen AH Jacobs HS A controlled study comparing patients with and without polycystic ovaries undergoing in vitro fertilization Human Reproduction 8 1992 233 237
41. Macnamee MC Howles CM Edwards RG Short term luteinizing hormone releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilization Fertility and Sterility 52 1989 264 269
42. Macrow PJ Li TC Seif MW Endometrial structure after superovulation: a prospective controlled study Fertility and Sterility 61 1994 696 699
43. Martin KA Hall JE Adams JM Crowley WF Comparison of exogenous gonadotrophins and pulsatile gonadotrophin releasing hormone for induction of ovulation in hypogonadotrophic amenorrhea Journal of Clinical Endocrinology and Metabolism 77 1993 125 129
44. Matta WH Shaw RW Burford GD Endocrinologic and clinical evaluation following a single administration of a gonadotrophin releasing hormone agonist (Zoladex) in a depot formulation to premenopausal women Fertility and Sterility 49 1988 163 165
45. van der Meer S Gerris J Joostens M Tas B Triggering of ovulation using gonadotrophin-releasing hormone agonist does not prevent ovarian hyperstimulation syndrome Human Reproduction 8 1993 1628 1631
46. 125I-luteinizing hormone releasing hormone Journal of Clinical Endocrinology and Metabolism 37 1973 63 67
47. Naor Z Leifer AM Catt KJ Calcium dependent actions of GnRH on pituitary 3′,5′c-GMP production and gonadotrophin release Endocrinology 107 1980 1438 1445
48. Neveu S Hedon B Bringer J Ovarian stimulation by a combination of gonadotrophin releasing hormone agonist and gonadotrophins for in vitro fertilization Fertility and Sterility 47 1987 639 643
49. Pellicer A Tarin JJ Miro F The use of gonadotrophin-releasing hormone analogues (GnRH-a) in in-vitro fertilization: some clinical and experimental investigations of a direct effect on the human ovary Human Reproduction 7 supplement 1 1992 39 47
50. Porter RN Smith W Craft IL Induction of ovulation for in vitro fertilization using buserelin and gonadotrophins Lancet ii 1984 1284 1285
51. Rajfer J Handelsman DJ Crum A Comparison of the efficacy of subcutaneous and nasal spray buserelin treatment in suppression of testicular steroidogenesis in men with prostate cancer Fertility and Sterility 46 1986 104 110
52. Rizk B Aboulghar M Modern management of ovarian hyperstimulation syndrome Human Reproduction 6 1991 1082 1087
53. Ron-El R Herman A Golan A The comparison of early follicular and midluteal administration of long-acting gonadotrophin releasing hormone agonist Fertility and Sterility 54 1990 233 237
54. San Roman GA Surrey ES Judd HL Kerin JF A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotrophin-releasing hormone agonist for in vitro fertilization Fertility and Sterility 58 1992 744 749
55. Sandow J Donnez J Clinical pharmacokinetics of LHRH analogues Sandow J The Present Place of LHRH Analogues in Gynaecology 1987 Parthenon Lancaster 1 12
56. Sandow J Fraser HM Seidel H Buserelin: pharmocokinetics, metabolism and mechanisms of action British Journal of Clinical Practice 41 supplement 48 1987 S6 S13
57. Scheele F Hompes PG van der Meer M Pulsatile gonadotrophin-releasing hormone stimulation after medium-term pituitary suppression in polycystic ovary syndrome Human Reproduction 8 supplement 2 1993 197 199
58. Schoot DC Pijlman B Stijnen T Fauser BC Effects of gonadotrophin releasing hormone agonist addition to gonadotrophin induction of ovulation in polycystic ovary syndrome patients European Journal of Obstetrics and Gynecology and Reproductive Biology 45 1992 53 58
59. Schwartz J Jewelewicz R The use of gonadotrophins for induction of ovulation Fertility and Sterility 35 1981 3 12
60. Shaker AG Pittrof R Zaidi J Administration of progestogens to hasten pituitary desensitization after the use of gonadotrophin releasing hormone agonist in in vitro fertilization—a prospective randomized study Fertility and Sterility 64 1995 791 795
61. Shaker AG Zosmer A Dean N Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome Fertility and Sterility 65 1996 992 996
62. Stein IF Leventhal ML Amenorrhea associated with bilateral polycystic ovary syndrome American Journal of Obstetrics and Gynecology 29 1935 181 191
63. Stephenson PA The risks associated with ovulation induction Iatrogenics 1 1991 7 11
64. Steptoe PC Edwards RG Laparoscopic recovery of pre-ovulatory human oocytes after priming of ovaries with gonadotrophins Lancet i 1970 683 689
65. Surrey ES de Ziegler D Lu JHK Effects of gonadotrophin-releasing hormone (GnRH) agonist on pituitary and ovarian responses to pulsatile GnRH therapy in polycystic ovarian disease Fertility and Sterility 52 1989 547 552
66. Takahashi K Okada M Ozadi T Transvaginal ultrasound morphology in polycystic ovarian syndrome Gynecology and Obstetric Investigation 39 1995 201 206
67. Tan SL Simplifying in vitro fertilization therapy Current Opinion in Obstetrics and Gynecology 6 1994 111 114
68. Tan SL Gonadotrophin-releasing hormone agonists in ovulation induction Filicori M Flamigni C The Ovary: Regulations, Dysfunction and Treatment 1996 Elsevier Amsterdam 403 412
69. Tan SL Balen A Hussein EE A prospective randomised study of the optimum timing of human chorionic gonadotrophin administration after pituitary desensitization in in vitro fertilization Fertility and Sterility 57 1992 1259 1264
70. Tan SL Kingsland C Campbell S The long protocol of administration of gonadotrophin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization Fertility and Sterility 57 1992 810 814
71. Tan SL Waterstone J Wren M Parsons J A prospective randomized study comparing aspiration only with aspiration and flushing for transvaginal ultrasound-directed oocyte recovery Fertility and Sterility 58 1992 356 360
72. Tan SL Maconochie N Doyle P Cumulative conception and live birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotrophin-releasing hormone agonist buserelin American Journal of Obstetrics and Gynecology 171 1994 513 520
73. Tan SL Farhi J Homburg R Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH Obstetrics and Gynecology 88 1996 221 226
74. Tan SL Morris D Tulandi T The role of gonadotrophin-releasing hormone and its agonists in infertility Seibel MM Infertility: a Comprehensive Text 2nd edn 1996 Appleton & Lange Stamford 537 556
75. Wada I Matson PL Troup SA Leiberman BA Assisted conception using buserelin and human menopausal gonadotrophins in women with polycystic ovary syndrome British Journal of Obstetrics and Gynaecology 100 1993 365 369
76. Werlin LB Hodgen GD Gonadotrophin-releasing hormone agonist suppresses ovulation, menses, and endometriosis in monkeys: an individualized intermittent regimen Journal of Clinical Endocrinology and Metabolism 56 1983 844 848
77. Zaidi J Campbell S Pittrof R Ovarian stromal blood flow in women with polycystic ovaries—a possible new marker for diagnosis? Human Reproduction 10 1995 1992 1996